Skip to Content
Merck
All Photos(1)

Key Documents

Safety Information

218746

Sigma-Aldrich

Caspase-1 Inhibitor VI

≥95% (HPLC), powder, Caspase-1 inhibitor, Calbiochem®

Synonym(s):

Caspase-1 Inhibitor VI, Z-YVAD-FMK

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C31H39FN4O9
Molecular Weight:
630.66
UNSPSC Code:
12352200
NACRES:
NA.77

product name

Caspase-1 Inhibitor VI, Caspase-1 Inhibitor VI, Z-YVAD-FMK, is a potent, cell-permeable, and irreversible inhibitor of caspase-1, caspase-4, and caspase-5.

Quality Level

Assay

≥95% (HPLC)
≥95% (TLC)

form

powder

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze
desiccated

color

white

solubility

DMSO: 5 mg/mL

shipped in

ambient

storage temp.

−20°C

General description

A potent, cell-permeable and irreversible inhibitor of caspase-1 (ICE).
A potent, cell-permeable, and irreversible inhibitor of caspase-1 (ICE), caspase-4, and caspase-5.

Biochem/physiol Actions

Cell permeable: yes
Product does not compete with ATP.
Reversible: no

Warning

Toxicity: Standard Handling (A)

Sequence

Z-Tyr-Val-Ala-Asp(OMe)-CH₂F*

Other Notes

Thornberry, N.A., and Lazebnik, Y. 1998. Science 281, 1312.
Eldadah, B.A., et al. 1997. J. Neurosci. 17, 6105.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

218746-1MG:
218746-MG:
218746-250UG:


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Mouna Rahabi et al.
Cell reports, 30(13), 4386-4398 (2020-04-03)
Colonic macrophages are considered to be major effectors of inflammatory bowel diseases (IBDs) and the control of gut inflammation through C-type lectin receptors is an emerging concept. We show that during colitis, the loss of dectin-1 on myeloid cells prevents

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service